Nemaura Medical Granted UK Trademark “Meta Score,” a Digital Biomarker Term for its Metabolic Health Program
21 juil. 2022 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, July 21, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2022
30 juin 2022 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, June 30, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical to Present at the H.C. Wainwright Global Hybrid Investment Conference
19 mai 2022 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, May 19, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
Nemaura Medical to Present at the Maxim Group 2022 Virtual Growth Conference
24 mars 2022 16h24 HE
|
Nemaura Medical, Inc
Loughborough, England, March 24, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
Nemaura Medical Announces Fiscal Third Quarter 2022 Financial Results and Provides Business Update
14 févr. 2022 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Launches Metabolic Health Program for Employers and Insurers
13 janv. 2022 08h30 HE
|
Nemaura Medical, Inc
Launch into commercial markets offers opportunities for faster and wider adoption of Miboko program Loughborough, England, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)...
Nemaura Medical to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference
07 janv. 2022 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
Nemaura Medical Completes Initial Shipment of CGM Devices to UK Licensee
07 déc. 2021 09h00 HE
|
Nemaura Medical, Inc
Sales in UK expected to be followed by launches across major EU territories in 2022 Loughborough, England, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the...
Nemaura Medical to Present at the Benzinga Global Small Cap Conference
30 nov. 2021 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
Nemaura Medical Announces Fiscal Second Quarter 2022 Financial Results and Provides Business Update
15 nov. 2021 09h30 HE
|
Nemaura Medical, Inc
Loughborough, England, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...